Epstein Secrets

s for aid to state and local governments, school funding and Republican insistence on a liability shield for employers." The New Ynrk TIMPc (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

tleground state in his bid for re-election." The New York Times <https://www.nytimes.com/2020/09/22/us/politics/house-short-term-bill.html> (9/22, Cochrane, 18.61M) reports "House Democratic leaders had initially sought to advance the bill without the" farm aid, but "moderate Democrats who count farmers

. Bloomberg <https://www.bloomberg.com/news/articles/2020-09-22/pfizer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

y shield for employers." The New York Times <https://vvww.nytimes.com/2020/10/22/business/stimulus-deal-may-wait-until-after- election.html> (10/22, Cochrane, Broadwater, 18.61 M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

of the liberal Center for American Progress, on her past statements and her former organization's corporate donations." The New York Times (2/22, Cochrane, Rappeport, 20.6M) highlights that if she is not confirmed, Tanden "would be the first casualty for Mr. Biden, who has so far been able to win Sena

believes in science, not conspiracy theories." FDA Outlines Fast Path For New Vaccines, Booster Shots To Cover New Virus Variants. Bloomberg (2/22, Langreth, Cortez, 3.57M) reports, "Drugmakers won't have to perform massive trials for new vaccines or booster shots developed to combat worrisome new varian

s for aid to state and local governments, school funding and Republican insistence on a liability shield for employers." The New York Times (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

Trump had promised last week during a political rally in Wisconsin, a key battleground state in his bid for re-election." The New York Times (9/22, Cochrane, 18.61M) reports "House Democratic leaders had initially sought to advance the bill without the" farm aid, but "moderate Democrats who count farmer

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

Trump had promised last week during a political rally in Wisconsin, a key battleground state in his bid for re-election." The New York Times (9/22, Cochrane, 18.61M) reports "House Democratic leaders had initially sought to advance the bill without the" farm aid, but "moderate Democrats who count farmer

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo